Published on 2 Jun 2022 on Investor's Business Daily
Regeneron Pharmaceuticals Dives On $1.1 Billion Deal To Rival Merck In Cancer
On today's stock market, however, Regeneron stock toppled 4.3% to 630.70. Shares of Sanofi stock...
Published on 2 Jun 2022 on Investor's Business Daily
On today's stock market, however, Regeneron stock toppled 4.3% to 630.70. Shares of Sanofi stock...